Skip to main content

Roche obesity pill achieves positive results in early-stage trial

By The Wall Street Journal  
   July 18, 2024

The Swiss company said the drug showed clinically meaningful weight loss of 7.3% after four weeks of treatment.

Full story


Get the latest on healthcare leadership in your inbox.